Interview with Kernel CEO, Ryan Field | Psychedelic Invest

This has been a busy quarter for the psychedelic industry, particularly Lucy Scientific Discovery Inc. The company has announced three acquisitions in the past three months. These acquisitions create an interesting and unexpected pathway for the company. The NASDAQ-listed Lucy Scientific Discovery has greatly expanded its reach within the psychedelic, wellness, and cannabis industries this…

New Data on Capsid Inhibitor for HIV

MedPage Today brought together three expert leaders for a virtual roundtable discussion on HIV news from the IDWeek annual meeting: Moderator Monica Gandhi, MD, MPH,

November 14, 2023

Epinephrine Was First an Asthma Treatment

This is the first in an occasional series on the origin of commonly used medicines. When epinephrine was first discovered at the turn of the

November 25, 2023

With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment

CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701

June 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.